These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 22138614)
41. (18)Fluorine-fluorodeoxyglucose positron emission tomography/computed tomography total glycolytic volume in thymic epithelial neoplasms evaluation: a reproducible image biomarker. Bertolaccini L; Viti A; Lanzi E; Fortunato M; Chauvie S; Bianchi A; Terzi A Gen Thorac Cardiovasc Surg; 2014 Apr; 62(4):228-33. PubMed ID: 24477745 [TBL] [Abstract][Full Text] [Related]
42. Superiority of [ Shen X; Zhou X; Yao Y; Meng X; Song Y; Yang Z; Li N Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3414-3424. PubMed ID: 37316675 [TBL] [Abstract][Full Text] [Related]
43. 18F-fluorodeoxyglucose and 11C-acetate positron emission tomography are useful modalities for diagnosing the histologic type of thymoma. Shibata H; Nomori H; Uno K; Sakaguchi K; Nakashima R; Iyama K; Tomiyoshi K; Kaji M; Goya T; Suzuki T; Horio H Cancer; 2009 Jun; 115(11):2531-8. PubMed ID: 19326456 [TBL] [Abstract][Full Text] [Related]
44. Correlation sometimes implies causation: possible roles of correlation analysis between 18 fluorine-fluorodeoxyglucose positron emission tomography/computed tomography and thymic epithelial neoplasms. Bertolaccini L; Viti A; Cavallo A; Terzi A Eur J Cardiothorac Surg; 2013 Jul; 44(1):187-8. PubMed ID: 23337328 [No Abstract] [Full Text] [Related]
45. Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors? Lococo F; Cesario A; Treglia G Ann Nucl Med; 2014 Jul; 28(6):593-4. PubMed ID: 24728730 [No Abstract] [Full Text] [Related]
46. Reply to 'Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors?'. Chida M; Sakamoto S Ann Nucl Med; 2014 Jul; 28(6):595-6. PubMed ID: 24728731 [No Abstract] [Full Text] [Related]
47. Multiparameter diagnostic model based on Wang G; Du L; Lu X; Liu J; Zhang M; Pan Y; Meng X; Xu X; Guan Z; Yang J BMC Cancer; 2022 Aug; 22(1):895. PubMed ID: 35974323 [TBL] [Abstract][Full Text] [Related]
48. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms. Terzi A; Bertolaccini L; Rizzardi G; Luzzi L; Bianchi A; Campione A; Comino A; Biggi A Lung Cancer; 2011 Nov; 74(2):239-43. PubMed ID: 21439670 [TBL] [Abstract][Full Text] [Related]
49. ¹⁸F-FDG uptake on PET could be a predictive marker of excision repair cross-complementation group 1 (ERCC1) expression in patients with thoracic neoplasms? Kaira K; Endo M; Shukuya T; Kenmotsu H; Naito T; Ono A; Tsuya A; Nakamua Y; Takahashi T; Murakami H; Kondo H; Nakajima T; Yamamoto N Neoplasma; 2012; 59(3):257-63. PubMed ID: 22329847 [TBL] [Abstract][Full Text] [Related]
50. Clinical usefulness of PET/MRI in differentiating anterior mediastinal masses. Sugawara H; Ito K; Watanabe H; Morita T; Yatabe Y; Watanabe SI; Kusumoto M Nucl Med Commun; 2022 Jan; 43(1):92-99. PubMed ID: 34887372 [TBL] [Abstract][Full Text] [Related]
51. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report. Liu RS; Yeh SH; Huang MH; Wang LS; Chu LS; Chang CP; Chu YK; Wu LC Eur J Nucl Med; 1995 Dec; 22(12):1402-7. PubMed ID: 8586085 [TBL] [Abstract][Full Text] [Related]
52. Usefulness of positron-emission tomography for predicting the World Health Organization grade of thymic epithelial tumors. Kanou T; Funaki S; Minami M; Ose N; Kimura T; Fukui E; Watabe T; Shintani Y Thorac Cancer; 2022 Jun; 13(11):1651-1656. PubMed ID: 35460177 [TBL] [Abstract][Full Text] [Related]
53. Fully Automatic Quantitative Measurement of 18F-FDG PET/CT in Thymic Epithelial Tumors Using a Convolutional Neural Network. Han S; Oh JS; Kim YI; Seo SY; Lee GD; Park MJ; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS Clin Nucl Med; 2022 Jul; 47(7):590-598. PubMed ID: 35675135 [TBL] [Abstract][Full Text] [Related]
54. Diagnostic Value of Dual-time-point F-18 FDG PET/CT and Chest CT for the Prediction of Thymic Epithelial Neoplasms. Shinya T; Tanaka T; Soh J; Matsushita T; Sato S; Toyooka S; Yoshino T; Miyoshi S; Kanazawa S Acta Med Okayama; 2017 Apr; 71(2):105-112. PubMed ID: 28420891 [TBL] [Abstract][Full Text] [Related]
56. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study. Nakajo M; Kajiya Y; Tani A; Yoneda S; Shirahama H; Higashi M; Nakajo M Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231 [TBL] [Abstract][Full Text] [Related]
57. The role of nuclear medicine in the management of thymomas. Treglia G; Spitilli MG; Calcagni ML; Giordano A Ann Ital Chir; 2007; 78(5):371-4. PubMed ID: 18338540 [TBL] [Abstract][Full Text] [Related]
58. Imaging of a case of metaplastic thymoma on 18F-FDG PET/CT. Ishikawa Y; Kato K; Taniguchi T; Kawaguchi K; Yokoi K Clin Nucl Med; 2013 Dec; 38(12):e463-4. PubMed ID: 24212449 [TBL] [Abstract][Full Text] [Related]
59. ¹⁸F-FDG uptake on PET is a predictive marker of thymidylate synthase expression in patients with thoracic neoplasms. Kaira K; Yamamoto N; Endo M; Kenmotsu H; Naito T; Ono A; Murakami H; Ohde Y; Nakajima T; Takahashi T Oncol Rep; 2014 Jan; 31(1):209-15. PubMed ID: 24173608 [TBL] [Abstract][Full Text] [Related]
60. Texture analysis of Nakajo M; Jinguji M; Shinaji T; Nakajo M; Aoki M; Tani A; Sato M; Yoshiura T Br J Radiol; 2018 Feb; 91(1083):20170546. PubMed ID: 29182373 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]